Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients
The decision by an advisory committee may lead to Food [...]
The decision by an advisory committee may lead to Food [...]
A new treatment for sickle cell disease will change lives [...]
A professor at the City College of New York engaged [...]
A medical breakthrough has a history tangled up in questions [...]
Human research trials at the New York State Psychiatric Institute [...]
Because the pill works faster than other antidepressants and is [...]
A new analysis of older people who have never had [...]
A trial of donanemab, an experimental drug, found it modestly [...]
The F.D.A. gave full approval to the drug, but added [...]
Readers respond to Kate Pickert’s essay about the recent revolution [...]